E. I. Du Pont De Nemours And Company Stock Earnings Reports

Corteva delivered a strong start to 2026 with Q1 organic sales up 7% and operating EBITDA up 21% (margin expansion ~240 bps). Both Seed and Crop Protection reported double-digit EBITDA gains driven by price/mix, volume (notably new products and Spinosyns), cost productivity, and favorable currency. Management reaffirmed full-year guidance: operating EBITDA $4.0–$4.2 billion, operating EPS $3.45–$3.70, and margin goal ~22–23%. Key operational themes: continued royalty progress (moving to royalty positive later this year), strong demand for Enlist technologies (Enlist beans expected on ~65% of U.S. soybean acres), growth focus in Brazil (seed trait penetration entering double digits), expansion of biologicals and next-gen crop protection actives, and advancement of a new pure-play seed/genetics company named "Vylor" (focused on licensing, hybrid wheat, gene editing and biofuels). Separation of the two companies remains on track for Q4 with net dis-synergies trending favorably (originally $100M; $50M assumed in 2026 guide) and one-time separation costs expected around $350M. Capital allocation moves include a board-approved $1.5 billion discretionary pension contribution to support investment-grade standalone capital structures and ~ $500M of share repurchases planned in H1. Risks being monitored: geopolitical-driven oil price increases (modeled as a ~$40M headwind in 2026), tariff exposure, and second-half inventory/commodity timing. Management will provide fuller multi-year plans at the September Investor Day.